AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

Generating your feed, please be patient ...

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis | Zootzle